Allen et al., 2010 - Google Patents
QL-24. EXPLORING RELATIONSHIPS OF EXECUTIVE CONTROL AND INDEPENDENT FUNCTION: OBSERVATIONS OF COMPENSATION BEHAVIORS IN …Allen et al., 2010
View PDF- Document ID
- 4828542335938398993
- Author
- Allen D
- Carlson B
- Neelon V
- Giovanello K
- Publication year
- Publication venue
- Neuro-Oncology
External Links
Snippet
CONTEXT: Activation of the epidermal growth factor receptor (EGFR) pathway has been implicated with mediating treatment resistance in glioblastoma multiformes (GBMs). OBJECTIVES: To identify a subset of GBM patients who may benefit from the addition of …
- 208000003174 Brain Neoplasms 0 title description 16
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brown et al. | A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma | |
Goda et al. | Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors | |
Cassier et al. | Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour | |
Canter et al. | Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma | |
Lee et al. | EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases | |
Bronk et al. | Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma | |
Herrera et al. | The role of PET/CT in cervical cancer | |
Jalali et al. | Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma | |
Dearnaley et al. | Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects | |
van Baardwijk et al. | Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients | |
Wolff et al. | Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience | |
Monjazeb et al. | A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme | |
Reddy et al. | Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide | |
Walbert et al. | Recurrent high-grade glioma: a diagnostic and therapeutic challenge | |
Rutkowski et al. | Pleomorphic xanthoastrocytoma with anaplastic features: retrospective case series | |
Kim et al. | Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency | |
Harat et al. | Safety and efficacy of irradiation boost based on 18F-FET-PET in patients with newly diagnosed glioblastoma | |
Mochizuki et al. | Precision medicine in pediatric neurooncology: a review | |
Khasraw et al. | Bevacizumab for the treatment of high-grade glioma | |
You et al. | Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors | |
Levitt et al. | Controversies in the management of brain metastases | |
Kowalchuk et al. | Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas | |
McKenzie et al. | Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases | |
Jilla et al. | Impact of various prognostic factors on survival in glioblastoma: tertiary care institutional experience | |
Kotecha et al. | Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview |